[Clinical implications of positive peritoneal cytology in endometrial cancer].
Ren, Yu-lan; Wang, Hua-ying; Shan, Bo-er; Ping, Bo; Shi, Da-ren.
Zhonghua Fu Chan Ke Za Zhi
; 46(8): 595-9, 2011 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-22169518
Predictive Capacity of 3 Comorbidity Indices in Estimating Survival Endpoints in Women With Early-Stage Endometrial Carcinoma.
The Effect of Adenomyosis in Myometrial Invasion and Overall Survival in Endometrial Cancer.
Multicenter study comparing oncologic outcomes between two nodal assessment methods in patients with deeply invasive endometrioid endometrial carcinoma: A sentinel lymph node algorithm versus a comprehensive pelvic and paraaortic lymphadenectomy.
Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
The immunoexpression of p53 and Snail in endometrioid endometrial carcinomas.
Molecular genetic heterogeneity in undifferentiated endometrial carcinomas.
Patient compliance for postoperative radiotherapy and survival outcome of women with stage I endometrioid endometrial cancer.
Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial.
Clinicopathological significance and prognostic value of myoinvasive patterns in endometrial endometrioid carcinoma.
Immunohistochemical study of endometrial high-grade endometrioid carcinoma with or without a concurrent low-grade component: implications for pathogenetic and survival differences.